✦ LIBER ✦

Characterization of PGE2 receptor subtypes in human eosinophils

✍ Scribed by Mita, Haruhisa; Hasegawa, Maki; Higashi, Noritaka; Akiyama, Kazuo

Book ID: 119765812
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 95 KB
Volume: 110
Category: Article
ISSN: 1097-6825
DOI: 10.1067/mai.2002.127001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulation of human myometrial PGE2 rece

Modulation of human myometrial PGE2 receptor by GTP characterization of receptor subtype

✍ M. Hamon; J. Berthaut; A. Wisner; F. Dray; B. Descomps; H.Thaler Dao 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 848 KB

Characterisation of the PGE receptor sub

Characterisation of the PGE receptor subtype linked to activation of adenylate cyclase in human eosinophils

✍ E. Talpain; R.A. Armstrong 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Characterization of muscarinic receptor

Characterization of muscarinic receptor subtypes in human tissues

✍ E. Giraldo; F. Martos; A. Gomez; A. Garcia; M.A. Vigano'; H. Ladinsky; F. Sanche 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 453 KB

The prostaglandin e receptor subtype EP4

The prostaglandin e receptor subtype EP4 mediates PGE2-dependent plaque instability in humans

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Expression of PGE2 EP3 receptor subtypes

Expression of PGE2 EP3 receptor subtypes in the mouse preoptic region

✍ Ana Maria Vasilache; Josefin Andersson; Camilla Nilsberth 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 790 KB

Functional characterization of P2Y and P

Functional characterization of P2Y and P2X receptors in human eosinophils

✍ Marco Idzko; Stefan Dichmann; Elisabeth Panther; Davide Ferrari; Yared Herouy; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

Activation of purinoceptor by ATP induces in eosinophils various cell responses including calcium transients, actin polymerization, production of reactive oxygen metabolites, CD11b-expression, and chemotaxis. Here, the effect of ion channel-gated P2X and/or G protein-coupled P2Y receptor agonists AT